Amylin Explores Sale, Hires Bankers: Sources
April 23, 2012 at 08:55 AM EDT
Amylin Pharmaceuticals, which spurned a $3.5 billion takeover bid from Bristol-Myers Squibb and is fending off a lawsuit from activist investor Carl Icahn, started reaching out to potential buyers last week, sources familiar with the situation said on Sunday.